Cited by 383Complement system in diseasesAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Activation of the classical complement pathway in brain tissue of Alzheimer patients

McGeer, P.L., Akiyama, H., Itagaki, S., McGeer, E.G.·1989·Neuroscience Letters

DOI 10.1016/0304-3940(89)90843-4

Open this paper in CoChat — free account

Abstract

Positive immunohistochemical staining of Alzheimer brain tissue was obtained with antibodies to proteins associated with classical, but not the alternative, complement pathway. Clq, C3d, C4d are fractions of complement proteins that bind to tissue when the classical complement pathway is activated. Antibodies to these fractions stained senile plaques, dystrophic neurites and some neurofibrillary tangles. C5b-9 is the membrane attack complex which promotes cell lysis when assembled on the plasma membrane. An antibody to a neoantigenic site on this complex stained dystrophic neurites and many neurofibrillary tangles, but not extracellular amyloid. Properdin and fraction Bb of factor B, two proteins that bind to tissue when the alternative complement pathway is activated, were not detected immunohistochemically.

Integrity signals

Registry

Crossref · 10.1016/0304-3940(89)90843-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Self-citation
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Self-citation
Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 452
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by? protein immunostaining
YAMAGUCHI, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue
Itagaki, S., McGeer, P. L., & Akiyama, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90690-8 · Cited by 271
Self-citation
BASIC AND CLINICAL IMMUNOLOGY
Gatenby, P. A., & Axiak, S. M. (1988) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1988.tb02238.x · Cited by 269
An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia
Eikelenboom, P., & Stam, F. C. (1984) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890185 · Cited by 83

Show all 15 references

Research works printed but not linked: 1

Kolb, 1988, Development of a highly sensitive capture EIA for the quantitation of the SC5b-9 complex in human plasma using a monoclonal antibody reactive with a poly-C9 neoantigenic determinant, Complement, 5, 213

Sorted by citations

Items 301–383 of 383

Complement regulatory proteins and selective vulnerability of neurons to lysis on exposure to acetylcholinesterase antibody
Tang, H. J., & Brimijoin, S. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00249-1 · Cited by 8
Les lésions de la maladie d’Alzheimer. Perspectives thérapeutiques ?
Duyckaerts, C. J., Perruchini, C., Lebouvier, T., & Potier, M. (2008) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32832-8 · Cited by 9
Trophic Factors as Therapeutic Agents for Diseases Characterized by Neuronal Death
Koliatsos, V. E., & Mocchetti, I. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_28 · Cited by 8
Mass Spectrometric Methods for Biomolecular Characterization
Nelson, R. W., Krone, J. R., Tubbs, K. A., & Dogruel, D. (1998) · Springer eBooks · doi:10.1007/978-94-015-9046-4_19 · Cited by 8
Role of complement activation and disruption of the blood–brain barrier in the pathogenesis of multiple system atrophy
Shibata, M., Makioka, K., Nakamura, T., Kasahara, H., Yamazaki, T., Takatama, M., Okamoto, K., & Ikeda, Y. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137642 · Cited by 7
Alzheimer's disease clinical variants show distinct neuroinflammatory profiles with neuropathology
Boon, B. D. C., Frigerio, I., de Gooijer, D., Morrema, T. H. J., Bol, J. G. J. M., Galis, Y., Heymans, M. W., Bank, N. B., Murray, M. E., Amsterdam, N. A. B. C., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.13009 · Cited by 7
Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
Quint, W. H., Matečko‐Burmann, I., Schilcher, I., Löffler, T., Schöll, M., Burmann, B. M., & Vogels, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201334 · Cited by 7
Innate immunity in the nervous system
Ramaglia, V., & Baas, F. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17507-6 · Cited by 7
Maintenance and Regulation in Brain of Neurotransmission, Trophic Factors, and Immune Responses
Cotman, C. W., Kahle, J. S., & Korotzer, A. R. (1995) · Comprehensive physiology · doi:10.1002/cphy.cp110113 · Cited by 7
Potential Beneficial Effects of a Diet with Walnuts in Aging and Alzheimer’s Disease
Chauhan, A., & Chauhan, V. P. S. (2012) · Springer eBooks · doi:10.1007/978-94-007-5237-5_16 · Cited by 6
Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties.
Shiwany, N. A., Xie, J., & Guo, Q. (2009) · PubMed Central · Cited by 6
CELLULAR AND MOLECULAR BIOLOGY OF ALZHEIMER'S DISEASE AND ANIMAL MODELS
Sisodia, S. S., Martin, L. J., Walker, L. C., Borchelt, D., & Price, D. L. (1995) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00276-x · Cited by 6
Cerebrospinal fluid antibodies : an indicator for immune responses in alzheimer's disease
McRae‐Degueurce, A., & Dahlström, A. B. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80053-n · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Cerebrospinal Fluid Complement 4 Levels Were Associated with Alzheimer’s Disease Pathology and Cognition in Non-Demented Elderly
Zhou, J., Wang, Z., Sun, Y., Fu, Y., Li, D., Tan, L., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230513 · Cited by 5
Innate Immune Mechanisms in the Central Nervous System
Shastri, A., Yasmin, H., & Kishore, U. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-85340-1_15 · Cited by 4
Inflammatory Processes Exacerbate Degenerative Neurological Disorders
McGeer, P. L., McGeer, E. G., & Schwab, C. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_10 · Cited by 6
Self-citation
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients
Leavey, N., Hammond, S. P., Shepstone, L., Cross, J., Zetterberg, H., Cunningham, C. M., MacLullich, A. M. J., Watne, L. O., Minihane, A. M., Ballard, C. G., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1447-7 · Cited by 5
Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer’s disease?
Nelson, R. B., Rose, K. N., Menniti, F. S., & Zorn, S. H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116258 · Cited by 5
Identification of a surface structure in the fourth component of human complement, C4, which becomes hidden upon activation by C1ˉs
Maeda, S., Takamaru, Y., Fukatsu, J., & Nagasawa, S. (1993) · Biochemical Journal · doi:10.1042/bj2890503 · Cited by 4
C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer’s modelPreprint
Schartz, N. D., Liang, H. Y., Carvalho, K., Chu, S., Mendoza‐Arvilla, A., Petrisko, T. J., Gómez-Arboledas, Á., Mortazavi, A., & Tenner, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.22.554306 · Cited by 4
Complement System Activation by Amyloid Aggregates of Aβ(1-40) and Aβ(1-42) Peptides: Facts and Hypotheses
Yakupova, E. I., Bobyleva, L. G., Vikhlyantsev, I. M., & Bobylev, A. G. (2020) · BIOPHYSICS · doi:10.1134/s000635092001025x · Cited by 3
Complement Component C3 Loss leads to Locomotor Deficits and Altered Cerebellar Internal Granule Cell In Vitro Synaptic Protein Expression in C57BL/6 Mice
DeKorver, N. W., Chaudoin, T. R., Zhao, G., Wang, D., Arikkath, J., & Bonasera, S. J. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02480-0 · Cited by 3
SPECT/PET Findings in Lewy Body Dementia
Ducksbury, R., Whitfield, T. J., & Walker, Z. (2014) · Springer eBooks · doi:10.1007/978-3-642-54307-4_17 · Cited by 3
High-density lipoproteins at the interface between central nervous system and plasma lipoprotein metabolism
Robert, J., Cheng, W. H., Hayat, A., Ward-Able, T., & Wellington, C. L. (2015) · Clinical Lipidology · doi:10.2217/clp.14.64 · Cited by 3
Cerebrospinal fluid and serum antimicroglial antibodies: prospects for early diagnosis of Alzheimer′s disease
McRae‐Degueurce, A., & Ling, E. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.2.247 · Cited by 3
SPECT/PET Findings in Dementia with Lewy Bodies
Zabihi, S., Whitfield, T. J., & Walker, Z. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_17 · Cited by 3
Neuroinflammatory Environments Promote Amyloid-ß Deposition and Posttranslational Modification
Atwood, C., Smith, M. A., Martins, R. N., Tanzi, R. E., Roher, A. E., Bush, A. I., & Perry, G. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_12 · Cited by 3
Treatment Of Alzheimer’s Disease
Shihabuddin, L., & Davis, K. L. (2019) · CRC Press eBooks · doi:10.1201/9780429260353-29 · Cited by 3
Glial Cells in Alzheimer’s Disease
Mrak, R. E., & Griffin, W. S. T. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_3 · Cited by 3
New cerebrospinal fluid biomarkers in Alzheimer’s disease
Burchell, J. T., & Panegyres, P. K. (2017) · Future Neurology · doi:10.2217/fnl-2017-0009 · Cited by 3
Complement biosynthesis in human brain: Insights from single-nucleus transcriptomics of hippocampusPreprint
Nguyen, V. D., Bright, M., Zhou, Y., Morgan, B. P., & Zelek, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.06.652374 · Cited by 3
Roles of Innate Immunity and Inflammation in the Aging Brain
Okun, E., Chen, X., Bašta, M., & Mattson, M. P. (2011) · Oxidative stress and disease · doi:10.1201/b11014-2 · Cited by 2
Clinical Relevance: Cytokines in Alzheimer’s Disease
Summers, W. K. (2008) · Neuroimmune biology · doi:10.1016/s1567-7443(07)10024-7 · Cited by 2
C1q, the classical complement pathway protein binds Hirano bodies in Pick's disease
Singhrao, S. K. (2013) · Microscopy Research and Technique · doi:10.1002/jemt.22206 · Cited by 2
Cellular and molecular mechanisms of Alzheimer’s disease inflammation
Peery, H. E., Strohmeyer, R., & Rogers, J. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8350-4_1 · Cited by 2
Study of the complement activation by amyloid aggregates of smooth muscle titin in vitro
Yakupova, E. I., Bobylev, A. G., Bobyleva, L. G., & Vikhlyantsev, I. M. (2019) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321819.2019.1694943 · Cited by 2
Role of Calcium in Inflammation: Relevance to Alzheimer's Disease
Quadros, A. (2007) · doi:10.25148/etd.fi10022540 · Cited by 2
Easing the burden of Alzheimer's disease: therapeutic options
Baumel, B. S. (1998) · European Journal of Neurology · doi:10.1111/j.1468-1331.1998.tb00445.x · Cited by 2
S14 TRANSGENIC MICE MODELS FOR ALZHEIMER??S DISEASE
LEUVEN, F. V. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00033 · Cited by 2
The potential application of cyclo-oxygenase type 2 inhibitors to Alzheimer’s disease
Sandson, T. A., & Félician, O. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.4.519 · Cited by 2
Atomoxetine Drug Properties for Repurposing as a Candidate Alzheimer’s Disease Therapeutic Agent
Demsey, L. L., Burch, D., Lin, E., Quach, D., Podvin, S., Boyarko, B., Levey, A. I., Weinshenker, D., Edland, S. D., Galasko, D. R., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00502 · Cited by 2
The CNS Innate Immune System and the Emerging Roles of the Neuroimmune Regulators (NIRegs) in Response to Infection, Neoplasia and Neurodegeneration
W., J., Denizot, M., J., J., & Gasque, P. (2012) · InTech eBooks · doi:10.5772/37824 · Cited by 1
Significance of Complement Activation in Alzheimer’s Disease
Loeffler, D. A. (2008) · touchREVIEWS in Neurology · doi:10.17925/usn.2008.04.02.52 · Cited by 1
The Effect of Systemic Inflammation on Cognitive Function and Neurodegenerative Disease
Cunningham, C. M., & Skelly, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.010 · Cited by 1
Treatment of Alzheimer's Disease
Shihabuddin, L., & Davis, K. L. (1996) · Informa Healthcare eBooks · doi:10.1201/9781420048407.ch22 · Cited by 1
Precision Nutrition in Aging and Brain Health
Chen, S. T., & Small, G. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15315-0.00017-1 · Cited by 1
The Complement Cascade in Acute Brain Injury
McDowell, M. M., Shea, N. J., Gupta, G., & Connolly, E. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8915-3_5 · Cited by 1
Microglial Glutamate Transporters - Regulation of Expression and Possible Physiological Functions
Persson, M. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Neuroinflammation-Mediated Neurotoxin Production in Neurodegenerative Diseases
Floyd, R. A., & Hensley, K. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_8 · Cited by 1
Amyloid in Alzheimer’s Disease and Animal Models
Price, D. L., Lamb, B. T., Gearhart, J. D., Martin, L. J., Walker, L. C., Koo, E. H., Borchelt, D., & Sisodia, S. S. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_15 · Cited by 1
Yeast as a Model for Studying Aβ Aggregation, Toxicity and Clearance
Bharadwaj, P. (2011) · Australasian Journal of Paramedicine · Cited by 1
Proteomic investigation of blood-based biomarkers for the diagnosis of HIV-associated neurocognitive disorders
Murugan, B. D. (2015) · Open University of Cape Town (University of Cape Town) · Cited by 1
Interleukin-6 in Amyloid-Plaques: Beteiligung des Immunsystems bei der Pathogenese der Alzheimer-Demenz
Hüll, M., Strauss, S., Berger, T., Volk, B., & Bauer, J. (1996) · Springer eBooks · doi:10.1007/978-3-7091-6889-9_16 · Cited by 1
Untersuchungen über die Auswirkungen von Geschlecht und genetischem Hintergrund auf die Alzheimerpathologie im 5xFAD-Mausmodell
Nordmeyer, P. J. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5124
Glial Cells and Aβ Peptides in Alzheimer’s Disease Pathogenesis
Siu, G., Clifford, P., Kosciuk, M. C., Venkataraman, V., & Nagele, R. G. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_13
Microglial involvement in brain physiopathology: in vitro studies using rat primary cultures
Mengoni, I. (2014) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6466
Effect of proinflammatory activation on the neurosupportive functions of astrocytes
Steele, M. L. (2011)
Alzheimer's Disease: Risk Factors and Preventive Strategies
Tschanz, J. T., & Breitner, J. C. S. (2010) · doi:10.1002/9780470669600.ch47
Flavonoids as regulators of amyloid precursor protein processing
Cox, C. J. (2014) · The University of Bath Online Publications Store (The University of Bath)
Measurement by ELISA of Complement Factor 4 (C4) in the Rat Brain: Necessity for Removal of Cerebrovascular Proteins
Loeffler, D. A., & Camp, D. M. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9105-z
Implications of Human Umbilical Cord Blood Cells: An Immunotherapeutic Strategy for Alzheimer's Disease
Darlington, D. (2014) · Digital Commons - University of South Florida (University of South Florida)
Open peer commentary Inflammation and Alzheimer's disease
Akiyama, H., Barger, S. W., Barnum, S. R., Bradt, B. M., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M. R., Fiebich, B. L., et al. (2000)
Self-citation
Early lesions in Alzheimer’s diseases
Troncoso, J. C., Kawas, C. H., Pardo, C. A., & Rebolledo, F. A. (2006) · Plasticidad y Restauración Neurológica
Inflammation in the CNS and in Alzheimer’s Disease
Perry, V. H., Bell, M. D., & Anthony, D. C. (1996) · Springer eBooks · doi:10.1007/978-3-662-03248-0_9
for the Treatment of Alzheimer's Disease
Aisen, P. S. S. (2002)
Pathological Changes in the Elderly Human Brain
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2
Cellular and animal models of amyloid β-protein amyloidosis
Sisodia, S. S., Borchelt, D., & Price, D. L. (1995) · Elsevier eBooks · doi:10.1016/b978-012286965-5/50012-1
Microglia and Complement in Alzheimer's Disease with Cerebral Amyloid Angiopathy
Zabel, M. K. (2013) · The Scholars Repository - LLU (Loma Linda University)
Cortical neurons transgenic for human Abeta40 or Abeta42 have similar vulnerability to apoptosis despite their different amyloidogenic properties.
Shiwany, N. A., Xie, J., & Guo, Q. (2009) · PubMed Central · Cited by 6
Imaging Amnestic Mild Cognitive Impairment: Neuroinflammation, Beta-amyloid and Glutathione
Knezevic, D. (2016) · TSpace (University of Toronto)
Molecular Mechanisms of Neuroprotection and Cognitive Enhancement by an Alternative drug Centella asiatica
Ahuja, M. (2013)
Alzheimer's Disease
JAMISON, J. (2003) · Elsevier eBooks · doi:10.1016/b978-0-443-07193-5.50014-5
Biological Signatures of Disease in Neuro-Psychiatry as Inter-Theoretical Reduction
Stoyanov, D. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662009200331084634
Alzheimer’s Disease
Siman, R., & Greenberg, B. (1996) · Humana Press eBooks · doi:10.1007/978-1-59259-466-5_10
Literaturverzeichnis
(2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1787-5_7
Patrick L. McGeer and Edith Graef McGeer
(2001) · The History of neuroscience in autobiography · doi:10.1016/s1874-6055(01)80015-3
BIBLIOGRAPHY
(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8
Alzheimer Disease
Kraft, A. W., & Lee, J. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0064
ALZHEİMER HASTALIĞINDA KOMPLEMAN SİSTEMİN ROLÜ
Yirün, A., KÖSE, S. B. E., & Erkekoğlu, P. (2023) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1337722
Investigating the Therapeutic Potential of Uric Acid in Alzheimer's Disease: Insights from the cGMP-PKG Signaling PathwayPreprint
C, T. S., Li, L., Jiang, Q., Mao, Y., Wei, S., Lo, A., & Huang, D. (2024) · Research Square · doi:10.21203/rs.3.rs-3999543/v1
Maintenance and Regulation in Brain of Neurotransmission, Trophic Factors, and Immune Responses
Cotman, C. W., Kahle, J. S., & Korotzer, A. R. (1994) · Comprehensive physiology · doi:10.1002/j.2040-4603.1994.tb01685.x
Additional file 1 of Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Veteleanu, A., Stevenson-Hoare, J., Keat, S., Daskoulidou, N., Zetterberg, H., Heslegrave, A., Escott‐Price, V., Williams, J. H., Sims, R., Zelek, W. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23731000

Authors: McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G.
Affiliations: University of British Columbia (CA)
Corresponding author: McGeer, P.L.
ORCID: McGeer, P.L.
Akiyama, H.
Venue: Neuroscience Letters
Publisher: Elsevier BV
Published: 1989-12
Volume: 107
Issue: 1-3
Pages: 341-346
ISSN: 0304-3940 (ISSN-L)
DOI: 10.1016/0304-3940(89)90843-4
OpenAlex: W1980565738
Cited by: 383
References: 15
Citations by year: 2025: 5 · 2024: 10 · 2023: 7 · 2022: 6 · 2021: 12 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 17 · 2012: 10
FWCI: 3.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience Letters (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: classical complement pathway, Alzheimer's disease, complement activation, C1q, C3d, C4d, C5b-9 membrane attack complex, amyloid plaques, dystrophic neurites, neurofibrillary tangles, amyloid, alternative complement pathway, properdin, factor B
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Inclusion Bodies, Complement Activation, Complement Pathway, Classical, Complement C4, Humans, Immunohistochemistry, Neurofibrils, Peptide Fragments, Complement C1q, Complement C3d, Complement C4b, Complement Membrane Attack Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of the classical complement pathway in brain tissue of Alzheimer patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks